Factor quinolinone inhibitors alter cell morphology and motility by destabilizing interphase microtubules
Abstract Factor quinolinone inhibitors are promising anti-cancer compounds, initially characterized as specific inhibitors of the oncogenic transcription factor LSF (TFCP2). These compounds exert anti-proliferative activity at least in part by disrupting mitotic spindles. Herein, we report additiona...
Main Authors: | Patrick Stoiber, Pietro Scribani Rossi, Niranjana Pokharel, Jean-Luc Germany, Emily A. York, Scott E. Schaus, Ulla Hansen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-02962-0 |
Similar Items
-
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins.
by: Sarah A Yunes, et al.
Published: (2022-01-01) -
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins
by: Sarah A. Yunes, et al.
Published: (2022-01-01) -
Not all benzimidazole derivatives are microtubule destabilizing agents
by: In-ho Song, et al.
Published: (2023-08-01) -
HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel
by: Michela Sgubin, et al.
Published: (2022-05-01) -
Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy
by: Myriam González, et al.
Published: (2021-02-01)